- 12 oral surgery updates in 2026
- 5 ASC, MOB deals in California
- Hidden OR capacity challenges: 8 perioperative leaders on what’s draining surgical time
- The Aspen Group’s 3-year growth recap: 40 moves
- Florida State University set to acquire Tallahassee hospital
- How Confusing Financial Journeys Undermine Revenue and Trust
- How Confusing Financial Journeys Undermine Revenue and Trust
- Misalignment, Not Malice: Rethinking Generational Conflict in Healthcare
- If AI ‘adds friction, it fails’: How Mayo Clinic scales technology
- As maternity units close, AdventHealth restores OB care in rural Kansas
- Oklahoma officials warn of new opioid
- The new metrics of healthcare technology ROI: What matters to healthcare leaders
- Hoag to launch transplant center in 2027
- MercyOne hospital to transition labor and delivery services
- MercyOne hospital to transition labor and delivery services
- Southeast metros lead US population growth as national gains slow
- 8 Medicare Advantage numbers to know in 2026
- 17 Senate Dems push back on 2027 ACA proposal
- Providence hospital closes inpatient pediatric unit
- Michigan finalizes Medicaid mental health assessment policy changes
- 10 financial notes on USPI’s growth over the past 3 years
- 15 new orthopedic practice, center openings in Q1
- The oral surgery technological revolution
- From Anxiety to Action: How Ambulatory Leaders Are Rebuilding Margins in 2026
- Where GI training may fall short
- What it took to become the world’s first ASC to offer Stryker’s robotic knee tech
- Medtronic’s win in spinal cord stimulator lawsuit upheld
- How the Trump Administration Uses Migrant Kids To Find and Detain Family Members
- Heartland Dental’s 3-year growth recap: 30+ moves
- Cencora’s $10B+ physician acquisition spree: A breakdown
- Tennessee physician practice acquired
- The FTC is coming for healthcare consolidation: 10 things physicians need to know
- Adventist Health sees momentum from insourcing revenue cycle operations
- Oral GLP-1s, COVID preventatives: 3 more drugs in the pipeline, Optum says payers should watch
- Unlicensed dentistry cases, DSO deals, legislation & more: 10 dentistry updates in Virginia
- Missouri system debuts mobile behavioral health unit
- Yale researchers study GLP-1’s potential for SUD
- Texas dental school receives $6.5M to expand pediatric dental, medical programs
- North Carolina autism provider to expand therapy access
- $3M Verdict Links Social Media to Anxiety and Depression
- West Virginia hospital to end OB delivery services
- 6 DSOs making headlines
- California hospital’s finances improve, cash position remains ‘dire’
- 1 in 5 metro markets face inpatient monopoly: 7 notes
- Minnesota system faces uncertainty amid Medicare delays
- Ohio county approves behavioral health crisis center plan
- The White House Delays CDC Pick
- New COVID 'Cicada' Variant Is Spreading — What Experts Want You To Know
- Op-ed: Empathy meets efficiency—how the responsible use of AI can transform Medicare
- Family Caregivers Provide $1 Trillion In Annual Labor, AARP Says
- ‘Health Doesn’t Need to Be Ludacris’: Bayer signs rapper-actor to multivitamin campaign
- Rocket plots measured trajectory for new gene therapy Kresladi after clearance to launch from FDA
- Healthy Lab Results May Mask Future Risks for Kids with Obesity
- At-Home Chemotherapy Is Safe, Feasible, Pilot Study Indicates
- What You Do While Sitting Could Predict Dementia Risk
- New Cholesterol Guidelines: What Patients and Caregivers Need to Know
- Want A Bootlicking Yes Man? Ask An AI Chatbot For Advice, Study Warns
- Specially Coated Implants Better For Breast Cancer Patients, Study Finds
- Trump Team Claims Successes Against ACA Fraud While Pushing for More Controls
- Give and Take: Federal Rural Health Funding Could Trigger Service Cuts
- Fierce Pharma Asia—Takeda’s $1.3B reorg; India’s GLP-1 floodgates; Gilead’s $2.2B buy of a China NewCo
- Where are you with EUDAMED?
- Where are you with EUDAMED?
- HL7 Launches Real‑Time Medical Device Interoperability Accelerator
- HL7 Launches Real‑Time Medical Device Interoperability Accelerator
- Two GA Tech ATDC Startups — Nephrodite and OrthoPreserve — Secure FDA Breakthrough Device Designation
- Two GA Tech ATDC Startups — Nephrodite and OrthoPreserve — Secure FDA Breakthrough Device Designation
- Artificial Intelligence: ROI, not Clinical Autonomy, Leads Operational Workflows
- Artificial Intelligence: ROI, not Clinical Autonomy, Leads Operational Workflows
- Medtronic and Merit Medical Systems distribution agreement for new, ViaVerte basivertebral nerve ablation system
- Medtronic and Merit Medical Systems distribution agreement for new, ViaVerte basivertebral nerve ablation system
- Breakthrough Device Designation for Noah Labs Vox Heart Failure Detection Device
- Breakthrough Device Designation for Noah Labs Vox Heart Failure Detection Device
- Why private practice dentistry needs a better model
- CareQuest Innovation Partners, Kno2 collab on medical-dental data integration
- Nonprofit highlights rural opioid care strategies
- Vitana Pediatric & Orthodontic Partners adds Florida practice
- What the Health? From KFF Health News: A Headless CDC
- 20 behavioral health leaders challenge industry assumptions
- Recordati confirms it's weighing CVC Capital buyout offer of $12.6B
- 3 California behavioral health centers to close amid funding shifts
- Indiana bars autism therapy provider from Medicaid billing: Wall Street Journal
- UnitedHealth shareholder sues over proposal to include details on integration in annual proxy
- SCAN taps biopharma, CMS vet Aman Bhandari as its first chief AI officer
- Infosys to acquire Optimum Healthcare IT in $465M deal
- DOJ alleges NewYork-Presbyterian forces payers into anticompetitive 'all-or-nothing' contracts
- FDA Warns Biotech Firm Over Cancer Drug Anktiva Claims
- Bees and Hummingbirds May Be Consuming Small Amounts of Alcohol
- Two States Sue Cord Blood Company Over Misleading Claims
- New WHO Guidance Aims To Speed Tuberculosis Testing
- As questions swirl around ATTR competition, Alnylam plots path to market leadership for Amvuttra
- Trump admin delays nomination for new CDC director past deadline
- Outspoken ACIP member steps down amid vaccine panel uncertainty: reports
- Egg-based drugmaker Neion Bio emerges from stealth to cook up multi-product biosimilar collab
- Genentech walks the walk in lupus as sponsor of annual awareness and fundraising event
- Study Reveals How Many Americans Consider Using a Gun
- Massive Study Finds Stress and Grief Don’t Cause Cancer
- Ultra-Processed Foods Harm Fertility In Both Men And Women, Studies Reveal
- Small Daily Habits Can Add Up To Better Heart Health
- Ritalin Might Protect ADHD Kids' Long-Term Mental Health, Study Finds
- Can You Drink Enough Fluids To Prevent Kidney Stones? Maybe Not, New Study Says
- Clasp, loan-linked hiring tool for employers, clinches $20M to expand amid federal loan caps
- Taking a GLP-1? Doctors Say Not To Forget About Movement and Mental Health
- OpenEvidence rolls out AI medical coding feature
- CDC’s Acting Chief Promises a Return to Stability in a Tumultuous Moment
- Remarks at the Financial Stability Oversight Council Meeting
- RWJF: Between 5M and 10M people could lose Medicaid coverage in 2028 under work requirements
- New therapy animal program aims to support 100K patients, providers
- Pulse check on Lilly's GLP-1 fortunes
- Gen Z nurses prioritize schedule flexibility, need more manager interactions to avoid turnover
- How pharma marketers can capitalize on HCPs’ AI, social media and streaming habits
- Federal Officials Investigate States That Require Abortion Coverage
- Corcept's lead drug bounces back from FDA snub with different approval as Lifyorli in ovarian cancer
- Ionis slashes Tryngolza's price tag by 93% ahead of anticipated label expansion
- FDA approves Denali's Hunter syndrome drug, handing rare disease community a win
- Baby Walkers Sold on Amazon Recalled Over Fall Risk
- Want To Protect Your Brain? Science Says Exercise
- HelloFresh Pizza Recall Issued in 10 States Over Metal Risk
- Clinical Trials Have Too Much Data…That’s the Problem.
- Clinical Trials Have Too Much Data…That’s the Problem.
- CMS reveals new Medicaid model that supports coordination for children with complex needs
- Novartis sued by breast cancer patient over branded drug websites’ data-sharing practices
- Takeda targets $1.3B in cost savings in further restructuring
- Biogen pays $20M upfront to tap into Alteogen's subQ delivery tech
- 'Universal Donor' Blood Supplies Dangerously Low, Study Warns
- Why Stepping Outside May Help You Eat Better
- U.S. Medicine, Science Facing An Online Misinformation Siege, Poll Concludes
- Childhood Obesity Undercuts The American Dream For Some, Study Says
- Inclusive High Schools Benefit All Students, Not Just LGBTQ Teens
- Parental Loss Due to Drugs, Violence Raises Child Death Risk by 2,000%
- As Boehringer touts US launches, board chairman worries EU is 'falling further behind'
- The evolving state of exome and genome sequencing
- Demoralized CDC Workforce Reels From Year of Firings, Funding Cuts, and a Shooting
- An Arm and a Leg: Steep Health Care Costs Steer Americans to Tough Decisions
- Qualified Health locks in $125M in fresh funding to scale enterprise AI at health systems
- Misery Loves [Investment] Company?: Remarks at the 2026 Investment Company Institute Investment Management Conference
- Study: Nearly 1 in 5 pediatric hospital deaths involve sepsis
- As expansions come online, CDMO Hovione aims to meet industry's 'dual supply and sourcing' zeal: exec
- Opening Remarks at the Digital Asset Summit 2026
- CVS Caremark, FTC reach settlement in insulin pricing case
- UCB unveils plan to build $2B biologics plant near its US headquarters in Atlanta
- PeaceHealth sued over plans to tap out-of-state staffer ApolloMD for Oregon EDs
- New Lyme Disease Vaccine Shows Strong Results in Trial
- TrumpRx Adds Diabetes, COPD Drugs at Steep Discounts
- Highmark reports $175M net loss for 2025 as financial headwinds batter health plan
- Listen to the Latest ‘KFF Health News Minute’
- Abivax hires commercial chief from Takeda to infuse Entyvio expertise into IBD launch prep
- ImmunityBio hit with FDA warning letter over Anktiva promotions in TV ad, podcast episode
- Alcohol Prep Pads Recalled Over Bacteria Risk, Cardinal Health Says
- Fewer patients traveled for abortions in 2025 as telehealth care increased, report finds
Scott W. Atlas, M.D., is the Robert Wesson Senior Fellow in health care policy at the Hoover Institution of Stanford University and a fellow at Hillsdale College's Academy for Science and Freedom. From July to December 2020, he served as a Special Advisor to the President and a member of the White House Coronavirus Task Force. He was savaged by the COVID Nazis, but he was one of the few public health 'experts' free from the corrupting influence of Big Pharma and a steady hand in the storm:
Today’s Public Health Emergency: Restoring Trust With Seven Steps
October 30, 2023
The public health emergency of the SARS2-CoV pandemic ended long ago, but America faces a new emergency. Faith in health agencies has plummeted more rapidly since 2019 than any other government institution, with almost two-thirds now rating the FDA and the CDC as “only fair or poor.” Half of America no longer has much confidence in science itself.The loss of trust is part of the disgraceful legacy of those who held power during the pandemic. Two presidents and dozens of governors hid behind public health bureaucrats Anthony Fauci, Deborah Birx, Robert Redfield, and Rochelle Walensky. They ignored Henderson’s classic review 15 years earlier showing lockdowns were both ineffective and extremely harmful. They rejected the alternative, targeted protection, recommended as early as March 2020 by Ioannidis, Katz, and Atlas. Beyond a reckless disregard for foreseeable destruction from their policies, America’s leaders imposed sinful harms and long-lasting damage on our children, the totality of which may not be realized for decades. Mandatory school closings, forced isolation of teens and college students, and required injections of healthy children with experimental drugs attempting to shield adults will be a permanent black mark on America. And the truth cannot be denied – the Birx-Fauci lockdowns failed to stop the death and the spread of infection (see Bjornskov, Bendavid, Agrawal, Herby, and Kerpen) and inflicted tremendous harms, shifting the pandemic burden to low-income families to spare the affluent.
America’s next president needs to lead with strong reforms, because the Birx-Fauci stain on public health and science jeopardizes the credibility of all future health guidance. Here are some recommended initial executive orders:
- Clearly define by law “public health emergency” with strict time limits (e.g., two weeks), requiring legislation to extend. Human rights were violated in the United States. Guarantees of the most fundamental freedoms upon which this country was founded – speech, religion, assembly – were suddenly reversed, without limit, by lockdowners under the guise of “the science” and “safety.” The U.S., with freedoms explicitly defined as “endowed by their Creator,” must be managed in concert with its system of laws, even during health emergencies.
- Add term limits (e.g., six years) to all health agency positions, including top- and mid-level posts, after first cleaning house of all heads of CDC, NIH, and FDA. For instance, Anthony Fauci worked as a bureaucrat for 38 years. Such longevity accrues power and seems to inhibit dissenting voices, while setting up unhealthy relationships with outside parties, including the media.
- Forbid all drug royalty-sharing by employees of FDA, NIH, CDC, and forbid related private jobs for five years after government service. OpenTheBooks revealed that between 2009 and 2021, approximately 54,000 royalty payments totaling $325.8 million were paid by third party entities to NIH researchers, sources redacted. We know that Dr. Francis Collins, the NIH’s former director, received 21 payments and Dr. Anthony Fauci received 37 payments between 2010 and 2021. This shocking conflict of interest, with hundreds of agency employees garnering personal profit forcibly revealed by FOIA requests, is the most urgent among many reforms.
- Require full transparency of all FDA, CDC, and NIH discussions with immediate posting to public forums. Statements from all advisors in those meetings, such as the startling October 26, 2021, recommendation of Eric Rubin, M.D., FDA advisor for children’s COVID vaccines, that “we’re never going to learn about how safe this vaccine is [in children] unless we start giving it. That’s just the way it goes,” must be widely visible to the public.
- Restatement with executive order that the CDC and other health agencies are strictly advisory and do not have power to set laws or mandates. Limiting health agency power is a way to begin holding elected officials accountable to the citizens, rather than allowing the pretense of hiding behind those agencies.
- Decentralize today’s cartel of NIH funding that controls all academic science careers and university medical centers. More than 15 U.S. medical centers receive over $500 million each – per year – from the NIH, the dominant funder of all scientific research, to the tune of $45 billion per year. Leverage on individual university scientists who owe their careers to NIH funding explains the February 2020 Lancet publication concocted behind closed doors calling the lab origin of the SARS2 virus a “conspiracy theory”– perhaps to conceal NIH malfeasance overseen by Drs. Collins and Fauci, who sent more than $2 million taxpayer dollars to fund China’s dangerous gain-of-function research to circumvent our country’s restrictions. Instead, disseminating control of NIH funding across regions with block grants to states would reduce this grip on independent voices.
- Immediately halt all binding agreements or pledges to the World Health Organization. The U.S. is the largest funding nation to WHO activities, but the WHO record is abysmal. In addition to supporting China’s stonewalling, Director Tedros backed China’s reckless human rights violations, stating “the Chinese government is to be congratulated for the extraordinary measures it has taken to contain the outbreak,” even as it used pseudoscience to essentially imprison its citizens. WHO disregarded evidence in its guidelines on mitigation, censored its own staff for acknowledging limits of asymptomatic spread, and flipped fundamental definitions like “herd immunity“ to influence behavior, rather than to dispassionately inform with data. We must hope Tedros was joking when he said, “China is actually setting a new standard for outbreak response.” Blind to the obvious need for reassessment, the Biden administration’s ambassador to the WHO Pamela Hamamoto already promised “The United States is committed to the [WHO’s] Pandemic Accord” even without seeing the final version. In that Accord, the WHO will define “public health emergency” for other countries – the fundamental basis to justify restrictions on the public. What is the rationale for any sovereign nation to allow a third party to legally define and impose such a critical state?
Finally, American voters need to wake up and hold elected officials accountable. Without substantial reforms, the promised freedoms of the United States will have lost legitimacy.
In my view, public health is the backwater of US healthcare.
The need it met before the information age has long expired. Now, public health officials are simply desperate to prove they're still needed - usually for a progressive political agenda.
Limiting public health power is a great first step. Because funding = power, step one should be followed closely by massive reductions in spending.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.

















